We have previously demonstrated that enhanced expression of the selective EGFR ligand transforming growth factor α (TGFα) in cetuximab-resistant CRC cells is responsible for EGFR-MET interaction and subsequent MET phosphorylation and activation [12]. The gene discussed is TGFA; the disease is colorectal carcinoma.